| 000 | 02494 a2200625 4500 | ||
|---|---|---|---|
| 005 | 20250517020833.0 | ||
| 264 | 0 | _c20150911 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1545-5017 | ||
| 024 | 7 |
_a10.1002/pbc.25453 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPan, Wei-Kang | |
| 245 | 0 | 0 |
_aPropranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway. _h[electronic resource] |
| 260 |
_bPediatric blood & cancer _cAug 2015 |
||
| 300 |
_a1414-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aCell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aChromones _xpharmacology |
| 650 | 0 | 4 |
_aCinnamates _xpharmacology |
| 650 | 0 | 4 |
_aCyclin A2 _xbiosynthesis |
| 650 | 0 | 4 |
_aCyclin D2 _xbiosynthesis |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xbiosynthesis |
| 650 | 0 | 4 |
_aEndothelial Cells _xmetabolism |
| 650 | 0 | 4 |
_aHemangioma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aMorpholines _xpharmacology |
| 650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
| 650 | 0 | 4 |
_aNeoplasm Invasiveness _xpathology |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
| 650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNorepinephrine _xpharmacology |
| 650 | 0 | 4 |
_aPericytes _xmetabolism |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xbiosynthesis |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProliferating Cell Nuclear Antigen _xbiosynthesis |
| 650 | 0 | 4 |
_aPropranolol _xtherapeutic use |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xbiosynthesis |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-1 _xpharmacology |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xantagonists & inhibitors |
| 700 | 1 | _aLi, Peng | |
| 700 | 1 | _aGuo, Zheng-Tuan | |
| 700 | 1 | _aHuang, Qiang | |
| 700 | 1 | _aGao, Ya | |
| 773 | 0 |
_tPediatric blood & cancer _gvol. 62 _gno. 8 _gp. 1414-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/pbc.25453 _zAvailable from publisher's website |
| 999 |
_c24666588 _d24666588 |
||